This is a Validated Antibody Database (VAD) review about human KRT5, based on 243 published articles (read how Labome selects the articles), using KRT5 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT5 synonym: CK5; DDD; DDD1; EBS2; K5; KRT5A

Invitrogen
mouse monoclonal (2C2)
  • western blot; human; 1:100; fig 3c
Invitrogen KRT5 antibody (Thermo-Fisher, MA5-17057) was used in western blot on human samples at 1:100 (fig 3c). Am J Cancer Res (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT5 antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen KRT5 antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT5 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; dogs; fig 2g
Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunohistochemistry on dogs samples (fig 2g). Animals (Basel) (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT5 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT5 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT5 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT5 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT5 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT5 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen KRT5 antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; fig 1a
In order to attempt to understand the role of human airway basal cells and endothelial cells cross-talk in regulating basal cell stem/progenitor function, Invitrogen KRT5 antibody (ThermoFisher Scientific, MA5-12596) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Stem Cell Rev (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 1c
In order to attempt to understand the role of human airway basal cells and endothelial cells cross-talk in regulating basal cell stem/progenitor function, Invitrogen KRT5 antibody (ThermoFisher Scientific, PA1-37974) was used in immunocytochemistry on human samples (fig 1c). Stem Cell Rev (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT5 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:75; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen KRT5 antibody (Thermo Scientific, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:75 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen KRT5 antibody (Thermo Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (2C2)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to investigate the role of TGF-beta signaling in bladder cancer progression, Invitrogen KRT5 antibody (Thermo Fisher, MA5-17057) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT5 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3a
In order to show that targeting CCL2 expression in vivo maybe effective for treating triple negative breast cancer, Invitrogen KRT5 antibody (ThermoFisher, XM-26) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT5 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (XM26)
  • immunocytochemistry; human; fig 2a
  • western blot; human; fig 3h
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Invitrogen KRT5 antibody (Thermo Scientific, XM26) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 3h). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 2 ug/ml; fig 2e
In order to determine the role of JAG1 human basal cell differentiation, Invitrogen KRT5 antibody (ThermoFisher Scientific, PA1-37974) was used in immunocytochemistry on human samples at 2 ug/ml (fig 2e). Stem Cell Rev (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT5 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; mouse; 1:20; fig 1
In order to study induction of aggressive claudin-low and basal-like breast cancer by targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium, Invitrogen KRT5 antibody (NeoMarkers, XM26) was used in immunohistochemistry - paraffin section on mouse samples at 1:20 (fig 1). Breast Cancer Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT5 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT5 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT5 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (D5/I6 B4)
  • immunohistochemistry; human; ready to use
In order to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast, Invitrogen KRT5 antibody (Thermo Scientific, MS-1814-R7) was used in immunohistochemistry on human samples at ready to use. Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT5 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
domestic rabbit polyclonal
In order to investigate factors involved in the crosstalk between basal cells and endothelial cells, Invitrogen KRT5 antibody (Thermo Scientific, PA1-37974) was used . J Cell Sci (2015) ncbi
mouse monoclonal (XM26)
  • immunocytochemistry; human; fig 5
In order to use of estrogen receptor-positive breast cancer lines to study steroid induction of therapy-resistant cytokeratin-5-positive cells through a BCL6-dependent mechanism, Invitrogen KRT5 antibody (Thermo Scientific, MS-1896-S) was used in immunocytochemistry on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; human; fig 2
In order to examine the transcriptional regulation that dictates different bladder cancer subtypes, Invitrogen KRT5 antibody (Thermo Scientific, EP1601Y) was used in immunohistochemistry on human samples (fig 2). BMC Med Genomics (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT5 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT5 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT5 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT5 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; fig s9
In order to characterize human solid salivary adenoid cystic carcinoma and high frequency of loss of PTEN expression as a targeted therapy, Invitrogen KRT5 antibody (Thermo Scientific, MS-1896) was used in immunohistochemistry - paraffin section on human samples (fig s9). Oncotarget (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of Notch signaling in human basal cell differentiation, Invitrogen KRT5 antibody (Thermo Scientific, PA1-37974) was used . PLoS ONE (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT5 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; dogs; 1:100
  • immunohistochemistry - paraffin section; cat; 1:100
Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on dogs samples at 1:100 and in immunohistochemistry - paraffin section on cat samples at 1:100. J Comp Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT5 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT5 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to characterize two cases of primary thymic adenocarcinoma with enteric differentiation, Invitrogen KRT5 antibody (Thermo Scientific, clone D5/16 B4) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT5 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; mouse; 1:200
In order to investigate how DASC(p63/Krt5) regulates regeneration of tissue after influenza-induced lung damage, Invitrogen KRT5 antibody (Thermo, EP1601Y) was used in immunohistochemistry on mouse samples at 1:200. Nature (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT5 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT5 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to describe two cases of trichilemmal carcinoma, Invitrogen KRT5 antibody (Thermo Fisher Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:50. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT5 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study triple negative primary breast cancer biological characteristics and clinical outcome in older women in comparison to their younger counterparts, Invitrogen KRT5 antibody (Thermo Scientific, M26) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to compare meningiomas and mesotheliomas immunohistochemically, Invitrogen KRT5 antibody (Thermo Scientific, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT5 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT5 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT5 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:100
In order to determine the prevalence of BRCA1 germline mutations in young onset TNBC, Invitrogen KRT5 antibody (Zymed Laboratories, Clone D5/16B4) was used in immunohistochemistry on human samples at 1:100. Clin Transl Oncol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT5 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen KRT5 antibody (Zymed, clone D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Int J Clin Exp Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT5 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; tbl 3
In order to discuss alterations in claudin 1 localization in basal-like breast cancer subtype, Invitrogen KRT5 antibody (Life Technologies, D5/16B4) was used in immunohistochemistry on human samples (tbl 3). BMC Cancer (2013) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; 1:300; fig 3
In order to characterize Brazilian breast cancer cell lines, Invitrogen KRT5 antibody (Neomarkers, XM26) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 3). Oncol Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT5 antibody (Invitrogen, D5/16B4) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; dogs; 1:100
In order to determine the relationship between the molecular phenotype of the primary canine mammary tumors and lymph node metastasis, Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on dogs samples at 1:100. BMC Vet Res (2012) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; dogs; 1:100; tbl 2
In order to assess a panel of markers for the identification of four different myoepithelial cell morphological types in normal and neoplastic mammary glands, Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on dogs samples at 1:100 (tbl 2). ScientificWorldJournal (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT5 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT5 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT5 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen KRT5 antibody (Invitrogen, D5/16B4) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunocytochemistry; human; tbl 1
In order to establish and characterize an epithelial cell line derived from a breast carcinoma from a patient with a strong family history of breast cancer but no known breast cancer susceptibility mutation, Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunocytochemistry on human samples (tbl 1). In Vitro Cell Dev Biol Anim (2011) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2, 3, 4
In order to report a new clinical case of prostatic adenomas with abnormal p63 expression, Invitrogen KRT5 antibody (Invitrogen, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2, 3, 4). Int J Surg Pathol (2011) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:50
In order to determine the activation profile of EGFR, PDGFRB, and PDGFRA receptors and their downstream effectors in diffuse malignant peritoneal mesothelioma specimens, Invitrogen KRT5 antibody (Zymed, D5) was used in immunohistochemistry on human samples at 1:50. Eur J Cancer (2010) ncbi
mouse monoclonal (D5/I6 B4)
  • immunohistochemistry; human; 1:50
In order to determine the activation profile of EGFR, PDGFRB, and PDGFRA receptors and their downstream effectors in diffuse malignant peritoneal mesothelioma specimens, Invitrogen KRT5 antibody (Zymed, D5) was used in immunohistochemistry on human samples at 1:50. Eur J Cancer (2010) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT5 antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT5 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT5 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to determine the effects of chemical oxidation, photo-oxidation, and artificial drying on the degradation of immunoreactivity of tissue samples, Invitrogen KRT5 antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). J Clin Pathol (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT5 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT5 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT5 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT5 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
BioLegend
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2b
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2b). Front Oncol (2022) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Cancers (Basel) (2022) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; human; 1:1200; fig 3b
BioLegend KRT5 antibody (Biolegend, PRB-160P) was used in immunohistochemistry on human samples at 1:1200 (fig 3b). Cancers (Basel) (2021) ncbi
chicken polyclonal (Poly9059)
  • immunohistochemistry; mouse; 1:500; fig 2a
BioLegend KRT5 antibody (Biologend, 905901) was used in immunohistochemistry on mouse samples at 1:500 (fig 2a). Curr Res Toxicol (2021) ncbi
chicken polyclonal (Poly9059)
  • immunohistochemistry - paraffin section; rat; 1:1000; loading ...; fig s3d
BioLegend KRT5 antibody (Biolegend, 905903) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig s3d). PLoS Genet (2021) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; human; 1:50; loading ...; fig 1f
BioLegend KRT5 antibody (Covance Biologicals, PRB-160P) was used in immunohistochemistry on human samples at 1:50 (fig 1f). JCI Insight (2021) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig e4a
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig e4a). Nat Metab (2021) ncbi
chicken polyclonal (Poly9059)
  • immunohistochemistry; human; loading ...; fig 4f
BioLegend KRT5 antibody (Biolegend, 905904) was used in immunohistochemistry on human samples (fig 4f). Commun Biol (2020) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunocytochemistry; human; 1:50; loading ...; fig 2c
BioLegend KRT5 antibody (Biolegend, PRB-160P) was used in immunocytochemistry on human samples at 1:50 (fig 2c). Cancers (Basel) (2020) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s2e
BioLegend KRT5 antibody (BioLegend, PRB-160P) was used in immunohistochemistry on mouse samples at 1:500 (fig s2e). J Exp Med (2020) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; loading ...
BioLegend KRT5 antibody (Biolegend, Poly 19055) was used in immunohistochemistry on mouse samples . Oncogene (2020) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2s1a
BioLegend KRT5 antibody (Biolegend, 905501) was used in immunohistochemistry on mouse samples at 1:500 (fig 2s1a). elife (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:800; loading ...; fig 1f, 4e
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:800 (fig 1f, 4e). Cell Stem Cell (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; loading ...; fig 5e
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples (fig 5e). Cell (2019) ncbi
domestic rabbit polyclonal (Poly19055)
BioLegend KRT5 antibody (BioLegend, Poly19055) was used . Stem Cell Reports (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 2
BioLegend KRT5 antibody (Covance Babco, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2). Nat Commun (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse; loading ...; fig 1a
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on mouse samples (fig 1a). Nat Cell Biol (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse; loading ...; fig 3d
BioLegend KRT5 antibody (BioLegend, 905501) was used in immunocytochemistry on mouse samples (fig 3d). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; human; loading ...; fig 1c
BioLegend KRT5 antibody (Covance, PRB 160P-100) was used in immunohistochemistry on human samples (fig 1c). EMBO J (2019) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 3c
BioLegend KRT5 antibody (BioLegend, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 3c). Immunity (2018) ncbi
domestic rabbit polyclonal (Poly19055)
  • western blot; mouse; 1:200; fig 6e
BioLegend KRT5 antibody (Covance, 905501) was used in western blot on mouse samples at 1:200 (fig 6e). Development (2018) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3k
BioLegend KRT5 antibody (Covance, PRB-160P-100) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3k). PLoS Genet (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 1
In order to research the role for BMP4 i mouse ureter development, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:250 (fig 1). Hum Mol Genet (2017) ncbi
chicken polyclonal (Poly9059)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2s1c
  • immunohistochemistry - frozen section; human; 1:500; fig 3s1b, 4c
BioLegend KRT5 antibody (BioLegend, 905901) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 2s1c) and in immunohistochemistry - frozen section on human samples at 1:500 (fig 3s1b, 4c). elife (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1h
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig s1h). Nature (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2c
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2c). Nat Commun (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • western blot; human; fig 5b
In order to determine the effects of repeated diacetyl vapor exposures on 3D organotypic cultures of human primary tracheobronchial epithelial cells, BioLegend KRT5 antibody (Covance, PRB160P) was used in western blot on human samples (fig 5b). J Proteome Res (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, BioLegend KRT5 antibody (BioLegend, 905501) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3c). Breast Cancer Res (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
In order to study the effect of PIK3CA in breast cancer., BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on human samples (fig 4b). PLoS ONE (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:2000; loading ...
In order to report how hedgehog signaling and stromal composition impact prostate cancer, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:2000. Dis Model Mech (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5c
  • immunocytochemistry; human; 1:250; loading ...; fig 1c
In order to determine the role of 420 kinases in bi-lineage triple-negative breast cancer, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5c) and in immunocytochemistry on human samples at 1:250 (fig 1c). Oncotarget (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1b
In order to examine the differentiation potential of adult mammary stem cells, BioLegend KRT5 antibody (Covance, PRB160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1b). Nat Commun (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
In order to explore the interplay between p53 loss and Wnt/beta-catenin signaling in stem cell function and tumorigenesis, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Oncogene (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:4000; fig 7
In order to examine TGFBR1 and TGFBR2 mutations in human vemurafenib-induced skin lesions and in sporadic cutaneous squamous cell carcinoma, BioLegend KRT5 antibody (Covance, AF138) was used in immunohistochemistry on mouse samples at 1:4000 (fig 7). Nat Commun (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 3c
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 3c). Oncogene (2017) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunocytochemistry; human; 1:1000; loading ...; fig 2b
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on human samples at 1:1000 (fig 2b). Science (2016) ncbi
chicken polyclonal (Poly9059)
  • immunocytochemistry; human; 1:1000; loading ...; fig 2e
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, BioLegend KRT5 antibody (Covance, SIG-3475) was used in immunocytochemistry on human samples at 1:1000 (fig 2e). Science (2016) ncbi
domestic rabbit polyclonal (Poly19055)
BioLegend KRT5 antibody (Biolegend, 905501) was used . Nat Commun (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • flow cytometry; mouse; fig 2
BioLegend KRT5 antibody (covance, PRB-160P) was used in flow cytometry on mouse samples (fig 2). Stem Cell Reports (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; fig 4
In order to determine how basal cell proliferation can be limited through an FGFR1-SPRY2 signaling axis in the steady-state airway epithelium, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:500 (fig 4). Dev Cell (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1f
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 1f). Int J Biol Sci (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 2
In order to study an increase in susceptibility of mice bladder cancer by conditional expression of the androgen receptor, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 2
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2). Development (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse; 1:100; fig 3
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on mouse samples at 1:100 (fig 3). Stem Cell Reports (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; fig 7
BioLegend KRT5 antibody (Biolegend, PRB-160P) was used in immunohistochemistry on mouse samples at 1:500 (fig 7). Oncogene (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1b
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:200 (fig 1b). Oncogene (2016) ncbi
domestic rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:800; fig 4
In order to elucidate role of androgen signaling in beta-catenin-initiated prostate tumorigenesis, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 4). Oncogene (2016) ncbi
Abcam
domestic rabbit monoclonal (EPR1600Y)
  • immunocytochemistry; mouse; 1:100
Abcam KRT5 antibody (Abcam, ab75869) was used in immunocytochemistry on mouse samples at 1:100. Cell Mol Life Sci (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 3h
  • immunohistochemistry; mouse; loading ...; fig 4m
Abcam KRT5 antibody (Abcam, Ab53121) was used in immunohistochemistry on human samples at 1:100 (fig 3h) and in immunohistochemistry on mouse samples (fig 4m). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal
  • flow cytometry; human; fig 2e
Abcam KRT5 antibody (Abcam, ab193895) was used in flow cytometry on human samples (fig 2e). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3e
Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry on mouse samples at 1:500 (fig 3e). Cell Rep (2021) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3c
Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry - paraffin section on human samples (fig 3c). Commun Biol (2020) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 4f
Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry on mouse samples at 1:400 (fig 4f). elife (2020) ncbi
domestic rabbit monoclonal (EPR1600Y)
  • immunohistochemistry; mouse; 1:800; loading ...
Abcam KRT5 antibody (Abcam, ab75869) was used in immunohistochemistry on mouse samples at 1:800. Cell Res (2020) ncbi
domestic rabbit monoclonal
  • flow cytometry; human; loading ...; fig 1c
  • immunocytochemistry; human; loading ...; fig 3c
Abcam KRT5 antibody (Abcam, ab193895) was used in flow cytometry on human samples (fig 1c) and in immunocytochemistry on human samples (fig 3c). Cell Stem Cell (2020) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1f
Abcam KRT5 antibody (abcam, ab52635) was used in immunohistochemistry on mouse samples at 1:100 (fig 1f). Nature (2019) ncbi
domestic rabbit monoclonal (EP1601Y)
  • western blot; human; 1:500; loading ...; fig 4b
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3b
  • western blot; mouse; 1:500; loading ...; fig 4a
Abcam KRT5 antibody (Abcam, ab52635) was used in western blot on human samples at 1:500 (fig 4b), in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b) and in western blot on mouse samples at 1:500 (fig 4a). Biomol Ther (Seoul) (2019) ncbi
domestic rabbit monoclonal (EP1601Y)
  • mass cytometry; human; loading ...; fig 3a
Abcam KRT5 antibody (Abcam, ab52635) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry - paraffin section; rat; 1:250; loading ...; fig 3
Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry - paraffin section on rat samples at 1:250 (fig 3). Biosci Rep (2019) ncbi
domestic rabbit monoclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4b
Abcam KRT5 antibody (Abcam, ab193895) was used in immunohistochemistry on mouse samples at 1:100 (fig 4b). Cell Rep (2018) ncbi
domestic rabbit monoclonal (EP1601Y)
  • flow cytometry; human; loading ...; fig s1b
Abcam KRT5 antibody (Abcam, ab52635) was used in flow cytometry on human samples (fig s1b). Cell Rep (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4i
Abcam KRT5 antibody (Abcam, ab53121) was used in immunohistochemistry - paraffin section on mouse samples (fig 4i). Cell Rep (2018) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
Abcam KRT5 antibody (Abcam, 52635) was used in immunohistochemistry - paraffin section on human samples (fig 2a). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; domestic rabbit; loading ...; fig 86
In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam KRT5 antibody (Abcam, ab53121) was used in immunohistochemistry on domestic rabbit samples (fig 86). J Toxicol Pathol (2017) ncbi
mouse monoclonal (XM26)
  • immunocytochemistry; human; fig 4A
Abcam KRT5 antibody (Abcam, ab17130) was used in immunocytochemistry on human samples (fig 4A). Biomaterials (2017) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 4
Abcam KRT5 antibody (Abcam, ab17133) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1b
In order to determine if PIK3CA mutations contribute to tumor initiation, Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry - paraffin section on mouse samples (fig 1b). Oncogenesis (2016) ncbi
mouse monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
In order to investigate the interaction between breast cancer subtype and treatment using data from a breast cancer trial randomizing women to adjuvant chemotherapy, Abcam KRT5 antibody (Abcam, XM26) was used in immunohistochemistry - paraffin section on human samples (fig 2b). Clin Cancer Res (2017) ncbi
domestic rabbit monoclonal (EP1601Y)
  • immunohistochemistry; human; fig s3
Abcam KRT5 antibody (Abcam, ab52635) was used in immunohistochemistry on human samples (fig s3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EPR1600Y)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Abcam KRT5 antibody (Abcam, ab75869) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig 1
In order to assess mediation by androgen control of autoimmune regulator due to sex bias in CNS autoimmune disease, Abcam KRT5 antibody (Abcam, Ab53121) was used in immunocytochemistry on mouse samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EPR1600Y)
  • western blot; human; fig 7
Abcam KRT5 antibody (abcam, ab75869) was used in western blot on human samples (fig 7). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
Abcam KRT5 antibody (Abcam, ab53121) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (XM26)
  • immunocytochemistry; human; fig s2
Abcam KRT5 antibody (Abcam, XM26) was used in immunocytochemistry on human samples (fig s2). Biomaterials (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig 5a
In order to characterize airway epithelial cells derived from induced pluripotent stem cells, Abcam KRT5 antibody (abcam, ab53121) was used in immunocytochemistry on mouse samples (fig 5a). Cell Tissue Res (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (XM26)
  • flow cytometry; human; 1:20; loading ...; fig s3a
Santa Cruz Biotechnology KRT5 antibody (Santa Cruz, sc-58732) was used in flow cytometry on human samples at 1:20 (fig s3a). Sci Adv (2019) ncbi
mouse monoclonal (RCK103)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2e
Santa Cruz Biotechnology KRT5 antibody (Santa Cruz Biotechnology Inc, sc-32721) was used in immunohistochemistry - paraffin section on mouse samples (fig 2e). Carcinogenesis (2018) ncbi
mouse monoclonal (RCK103)
  • flow cytometry; human; fig 5
In order to use of estrogen receptor-positive breast cancer lines to study steroid induction of therapy-resistant cytokeratin-5-positive cells through a BCL6-dependent mechanism, Santa Cruz Biotechnology KRT5 antibody (Santa Cruz, sc-32721) was used in flow cytometry on human samples (fig 5). Oncogene (2016) ncbi
mouse monoclonal (RCK103)
  • immunocytochemistry; human; loading ...; fig 6a
Santa Cruz Biotechnology KRT5 antibody (Santa Cruz Biotechnology, sc-32721) was used in immunocytochemistry on human samples (fig 6a). Biores Open Access (2014) ncbi
mouse monoclonal (C50)
  • immunohistochemistry; mouse; 1:200; fig 8e
Santa Cruz Biotechnology KRT5 antibody (Santa Cruz Biotechnology, C50) was used in immunohistochemistry on mouse samples at 1:200 (fig 8e). Oncogene (2015) ncbi
mouse monoclonal (5F295)
  • immunohistochemistry - paraffin section; mouse; fig 3
Santa Cruz Biotechnology KRT5 antibody (Santa Cruz, sc-70928) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). PLoS ONE (2013) ncbi
Dako
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 3d
Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3d). J Clin Med (2021) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:100
Dako KRT5 antibody (Dako, Agilent, M7237) was used in immunohistochemistry on human samples at 1:100. Nat Commun (2021) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; cat; loading ...; fig st2
Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on cat samples (fig st2). Sci Rep (2020) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2b, 2f, 2n
Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2b, 2f, 2n). Tissue Eng Part A (2020) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; fig 6a
Dako KRT5 antibody (Dako, M723729) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6a). Nat Commun (2018) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:250; tbl 3
Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry on human samples at 1:250 (tbl 3). PLoS ONE (2017) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; dogs; 1:50; fig S1a,S2a,S3a,S4a
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on dogs samples at 1:50 (fig S1a,S2a,S3a,S4a). J Vet Med Sci (2017) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to determine the frequency of the apocrine subtype in triple-negative breast carcinomas from premenopausal patients, Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Rev Bras Ginecol Obstet (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:50; loading ...
In order to present the case of a patient with gingival and both palatine tonsils localization of a grade-two angiosarcoma, Dako KRT5 antibody (Dako, D5 16/B4) was used in immunohistochemistry on human samples at 1:50. Rare Tumors (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunocytochemistry; dogs; 1:100; tbl 5
In order to establish canine mammary tissue derived cell lines and study claudin expression, Dako KRT5 antibody (Dako, D5/16B4) was used in immunocytochemistry on dogs samples at 1:100 (tbl 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:25; tbl 1
In order to develop differential diagnoses for epithelioid mesothelioma with a solid growth pattern and poorly differentiated squamous cell carcinoma, Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:25 (tbl 1). Histopathology (2017) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to classify triple-negative breast cancer into subtypes, Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 3
In order to investigate evidence for two distinct pathogenetic pathways by studing the squamous cell carcinoma of the oral cavity and cytokeratin and protein expression patterns, Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 3). Oncol Lett (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
In order to examine a case of recurrent renal cell carcinoma manifesting in the thorax as a fibrotic mass, Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Oncol Lett (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; fig 1
In order to analyze the impact of breast cancer stem cell marker expression on clinical outcome and trastuzumab response in human epidermal growth factor receptor 2-positive breast cancer, Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on human samples (fig 1). Br J Cancer (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 2
In order to present the clinicopathological features of nine cases of renal cell carcinoma metastatic to the ovary or the fallopian tube, Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Hum Pathol (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Dako KRT5 antibody (DakoCytomation, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:25; loading ...
In order to explore the relationship between hnRNP A1 and RON tumoral expression, Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:25. Oncotarget (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100
In order to characterize diagnosis of asymptomatic benign papilloma without atypia via ultrasonography-guided 14-gauge core needle biopsy to determine a possible subgroup to monitor by observation, Dako KRT5 antibody (DAKO, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Surg Oncol (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:200
In order to characterize aggressive tumors in African breast cancer and the strong expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) and its association with Axl expression, Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - free floating section; human; fig 1
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry - free floating section on human samples (fig 1). Prostate (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:100
Dako KRT5 antibody (Dako, D5/16B4/) was used in immunohistochemistry on human samples at 1:100. Breast (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to study the breast tumor microenvironment and interleukin-6 and pro inflammatory status, Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples . World J Surg Oncol (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to analyze breast cancer subtypes and retrospective analysis of metastatic behaviour, Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunocytochemistry; human; fig 1
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunocytochemistry on human samples (fig 1). Immunol Cell Biol (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Hum Pathol (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 5
In order to analyze triple negative breast carcinomoas and their correlation with mesothelin expression and basal-like phenotype, decreased survival, and distant metastases, Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 5). PLoS ONE (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:25
In order to describe the histological features canalicular adenoma, Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on human samples at 1:25. Head Neck Pathol (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
Dako KRT5 antibody (DakoCytomation, M7237) was used in immunohistochemistry - paraffin section on human samples . J Immunol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study triple negative primary breast cancer biological characteristics and clinical outcome in older women in comparison to their younger counterparts, Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:25
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on human samples at 1:25. Pathol Res Pract (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:100
Dako KRT5 antibody (Dako, M7237) was used in immunohistochemistry on human samples at 1:100. Endocr Relat Cancer (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:25
Dako KRT5 antibody (DakoCytomation, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:25. Exp Hematol Oncol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100
Dako KRT5 antibody (Dako Corporation, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; ready-to-use
Dako KRT5 antibody (Dako, D5/16B4) was used in immunohistochemistry on human samples at ready-to-use. Pathol Res Pract (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:50. Mod Pathol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:300
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on human samples at 1:300. Breast Cancer Res Treat (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:50; loading ...
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry on human samples at 1:50. Hum Pathol (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:100
Dako KRT5 antibody (Dako, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:100. World Neurosurg (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (E2T4B)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig e2f
Cell Signaling Technology KRT5 antibody (CST, 71536) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig e2f). Nature (2021) ncbi
domestic rabbit monoclonal (E2T4B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6c
Cell Signaling Technology KRT5 antibody (Cell Signaling, 71536) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6c). Cell Biosci (2021) ncbi
domestic rabbit monoclonal (E2T4B)
  • immunohistochemistry; human; 1:2000; loading ...; fig s1-3
Cell Signaling Technology KRT5 antibody (Cell Signaling Technology, 71536) was used in immunohistochemistry on human samples at 1:2000 (fig s1-3). elife (2020) ncbi
domestic rabbit monoclonal (E2T4B)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology KRT5 antibody (Cell Signaling, 71536) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1b). Cell Death Dis (2020) ncbi
Agilent Technologies
monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:200; loading ...; fig 2d
Agilent Technologies KRT5 antibody (Agilent Technologies, M723729-2) was used in immunohistochemistry on human samples at 1:200 (fig 2d). Breast Cancer Res (2019) ncbi
MilliporeSigma
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2h
MilliporeSigma KRT5 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2h). J Clin Invest (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:200; loading ...; fig 7f, s4
  • immunohistochemistry; rat; 1:200; loading ...; fig 2d
MilliporeSigma KRT5 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on human samples at 1:200 (fig 7f, s4) and in immunohistochemistry on rat samples at 1:200 (fig 2d). Nat Commun (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Cancer Immunol Immunother (2020) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry; human; loading ...; fig 7a
MilliporeSigma KRT5 antibody (Sigma, C2931) was used in immunohistochemistry on human samples (fig 7a). Cell Rep (2018) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2a
MilliporeSigma KRT5 antibody (Sigma, C-11) was used in immunohistochemistry - frozen section on mouse samples (fig 2a). PLoS ONE (2018) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:50; fig 3a
MilliporeSigma KRT5 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on mouse samples at 1:50 (fig 3a). Science (2018) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig s4a
In order to discover that myoepithelial cells born early during submucosal gland morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types, MilliporeSigma KRT5 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s4a). Am J Respir Cell Mol Biol (2017) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; human; 1:100; loading ...; fig 6a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, MilliporeSigma KRT5 antibody (Sigma, C-11) was used in immunocytochemistry on human samples at 1:100 (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the role of Tsc2 in normal and pathological kidney and lung functions, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Am J Pathol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5a
In order to study how tumor hypoxia affects DNA methylation, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples (fig s5a). Nature (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; pigs ; 1:100; loading ...; fig 5h
In order to build and characterize a novel bioreactor platform, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on pigs samples at 1:100 (fig 5h). Biotechnol J (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:200
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; loading ...; fig 2b
MilliporeSigma KRT5 antibody (Sigma, c2562) was used in immunohistochemistry on human samples (fig 2b). Nat Biotechnol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; human; 1:200; fig 5
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunocytochemistry on human samples at 1:200 (fig 5). BMC Biol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:4000; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry on human samples at 1:4000 (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (C-11)
  • western blot; human; 1:1000; fig 1
MilliporeSigma KRT5 antibody (Sigma, C-2931) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; fig 2
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples (fig 2). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Fluids Barriers CNS (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Clin Cancer Res (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:800; fig 5
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:800 (fig 5). Dis Model Mech (2015) ncbi
mouse monoclonal (C-11)
  • western blot; rat
In order to characterize two new cell lines with the potential to be used to study portal (myo)fibroblasts, MilliporeSigma KRT5 antibody (Sigma-Aldrich, clone C-11) was used in western blot on rat samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; domestic sheep; 10 ug/ml; loading ...
In order to study the reprogramming of ovine induced pluripotent stem cells, MilliporeSigma KRT5 antibody (Sigma, C2931) was used in immunocytochemistry on domestic sheep samples at 10 ug/ml. Cell Reprogram (2015) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; Xenopus laevis
MilliporeSigma KRT5 antibody (Sigma, C2931) was used in immunocytochemistry on Xenopus laevis samples . Zygote (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to develop and validate a mouse model of endometriosis, MilliporeSigma KRT5 antibody (Sigma-Aldrich, #C2562) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Am J Pathol (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; rat
MilliporeSigma KRT5 antibody (Sigma, C2562) was used in western blot on rat samples . Carcinogenesis (2014) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
MilliporeSigma KRT5 antibody (Sigma-Aldrich, C-11) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100. Biomaterials (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; pigs
  • western blot; human; 1:10,000
MilliporeSigma KRT5 antibody (Sigma-Aldrich, C 2562) was used in western blot on pigs samples and in western blot on human samples at 1:10,000. Mol Oncol (2014) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; Gallot's lizard; 1:400
In order to study the histogenesis of the lizard visual system, MilliporeSigma KRT5 antibody (Sigma-Aldrich, C2931) was used in immunohistochemistry - paraffin section on Gallot's lizard samples at 1:400. J Comp Neurol (2012) ncbi
Leica Biosystems
  • immunocytochemistry; human; 1:200; loading ...; fig 4c
  • western blot; human; 1:1500; loading ...; fig 2e
Leica Biosystems KRT5 antibody (Leica Biosystems, NCL-L-CK5) was used in immunocytochemistry on human samples at 1:200 (fig 4c) and in western blot on human samples at 1:1500 (fig 2e). Oncogene (2020) ncbi
  • immunohistochemistry; human; loading ...; fig 3c
Leica Biosystems KRT5 antibody (Leica Biosystems, NCL-L-CK5) was used in immunohistochemistry on human samples (fig 3c). BMC Cancer (2019) ncbi
  • immunohistochemistry; human; 1:200; fig 6b
  • western blot; human; loading ...; fig 2c
Leica Biosystems KRT5 antibody (Leica Biosystems, NCL-L-CK5) was used in immunohistochemistry on human samples at 1:200 (fig 6b) and in western blot on human samples (fig 2c). Oncogene (2017) ncbi
monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1A
  • immunocytochemistry; human; loading ...; fig S1B
Leica Biosystems KRT5 antibody (Leica, XM26) was used in immunohistochemistry - paraffin section on human samples (fig 1A) and in immunocytochemistry on human samples (fig S1B). Oncotarget (2016) ncbi
monoclonal (XM26)
  • immunohistochemistry; human; 1:400; tbl 1
Leica Biosystems KRT5 antibody (Novocastra, XM26) was used in immunohistochemistry on human samples at 1:400 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
monoclonal (XM26)
  • immunohistochemistry - paraffin section; human; 1:800
In order to study the claudin expression in fibromatosis-like metaplastic carcinoma of the breast, Leica Biosystems KRT5 antibody (Novocastra, XM26) was used in immunohistochemistry - paraffin section on human samples at 1:800. Virchows Arch (2014) ncbi
monoclonal (XM26)
  • immunohistochemistry; human
In order to measure protein expression of insulin-like growth factor receptor pathway members and evaluate their prognostic significance across the different early breast cancer subtypes, Leica Biosystems KRT5 antibody (Novocastra, XM26) was used in immunohistochemistry on human samples . PLoS ONE (2014) ncbi
BD Biosciences
mouse monoclonal (RCK102)
  • immunocytochemistry; human; 1:100; loading ...; fig s3c
BD Biosciences KRT5 antibody (BD Biosciences, 550505) was used in immunocytochemistry on human samples at 1:100 (fig s3c). Sci Adv (2019) ncbi
mouse monoclonal (RCK102)
  • western blot; mouse; 1:1000; loading ...; fig 3d
In order to evaluate the effect of glucocorticoids in a mouse model of colitis, BD Biosciences KRT5 antibody (BD, 550505) was used in western blot on mouse samples at 1:1000 (fig 3d). Biochem Pharmacol (2016) ncbi
mouse monoclonal (RCK102)
  • western blot; human; loading ...; fig 2b
BD Biosciences KRT5 antibody (BD Biosciences, 550505) was used in western blot on human samples (fig 2b). Oncol Lett (2016) ncbi
Articles Reviewed
  1. Wakao S, Oguma Y, Kushida Y, Kuroda Y, Tatsumi K, Dezawa M. Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frame. Cell Mol Life Sci. 2022;79:542 pubmed publisher
  2. Mart xed nez Nieto G, Teppo H, Petrelius N, Izzi V, Devarajan R, Pet xe4 ist xf6 T, et al. Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis. Front Oncol. 2022;12:981009 pubmed publisher
  3. Malanga D, Laudanna C, Mirante T, Colelli F, Migliozzi S, Zoppoli P, et al. The AKT1E17K Allele Promotes Breast Cancer in Mice. Cancers (Basel). 2022;14: pubmed publisher
  4. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  5. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  6. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  7. Sekino Y, Pham Q, Kobatake K, Kitano H, Ikeda K, Goto K, et al. KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer. J Clin Med. 2021;10: pubmed publisher
  8. Tu N, Inoue K, Chen E, Anderson B, Sawicki C, Scheff N, et al. Cathepsin S Evokes PAR2-Dependent Pain in Oral Squamous Cell Carcinoma Patients and Preclinical Mouse Models. Cancers (Basel). 2021;13: pubmed publisher
  9. Zhang X, Tao J, Yu J, Hu N, Zhang X, Wang G, et al. Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis. Cell Death Dis. 2021;12:867 pubmed publisher
  10. Keil Stietz K, Kennedy C, Sethi S, Valenzuela A, Nunez A, Wang K, et al. In utero and lactational PCB exposure drives anatomic changes in the juvenile mouse bladder. Curr Res Toxicol. 2021;2:1-18 pubmed publisher
  11. Wohnhaas C, Gindele J, Kiechle T, Shen Y, Leparc G, Stierstorfer B, et al. Cigarette Smoke Specifically Affects Small Airway Epithelial Cell Populations and Triggers the Expansion of Inflammatory and Squamous Differentiation Associated Basal Cells. Int J Mol Sci. 2021;22: pubmed publisher
  12. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  13. Keshvari S, Caruso M, Teakle N, Batoon L, Sehgal A, Patkar O, et al. CSF1R-dependent macrophages control postnatal somatic growth and organ maturation. PLoS Genet. 2021;17:e1009605 pubmed publisher
  14. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  15. Liberti D, Kremp M, Liberti W, Penkala I, Li S, Zhou S, et al. Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury. Cell Rep. 2021;35:109092 pubmed publisher
  16. Lindskrog S, Prip F, Lamy P, Taber A, Groeneveld C, Birkenkamp Demtroder K, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021;12:2301 pubmed publisher
  17. Levi M, Muscatello L, Brunetti B, Benazzi C, Parenti F, Gobbo F, et al. High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals (Basel). 2021;11: pubmed publisher
  18. DePianto D, Heiden J, Morshead K, Sun K, Modrusan Z, Teng G, et al. Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population. JCI Insight. 2021;6: pubmed publisher
  19. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  20. Choi J, Sebastian C, Ferrer C, Lewis C, Sade Feldman M, LaSalle T, et al. A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma. Nat Metab. 2021;3:182-195 pubmed publisher
  21. Yuan G, Flores N, Hausmann S, Lofgren S, Kharchenko V, Angulo Ibáñez M, et al. Elevated NSD3 histone methylation activity drives squamous cell lung cancer. Nature. 2021;590:504-508 pubmed publisher
  22. McGuire J, Frieling J, Lo C, Li T, Muhammad A, Lawrence H, et al. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nat Commun. 2021;12:723 pubmed publisher
  23. Xu L, Zhang M, Shi L, Yang X, Chen L, Cao N, et al. Neural stemness contributes to cell tumorigenicity. Cell Biosci. 2021;11:21 pubmed publisher
  24. Dong B, Miao J, Wang Y, Luo W, Ji Z, Lai H, et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun Biol. 2020;3:778 pubmed publisher
  25. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  26. Mevel R, Steiner I, Mason S, Galbraith L, Patel R, Fadlullah M, et al. RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. elife. 2020;9: pubmed publisher
  27. Pan L, Lemieux M, Thomas T, Rogers J, Lipper C, Lee W, et al. IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. elife. 2020;9: pubmed publisher
  28. Pseftogas A, Xanthopoulos K, Poutahidis T, Ainali C, Dafou D, Panteris E, et al. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling. Cancers (Basel). 2020;12: pubmed publisher
  29. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  30. Luo P, Yan H, Chen X, Zhang Y, Zhao Z, Cao J, et al. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide. Cell Res. 2020;30:779-793 pubmed publisher
  31. Hermanova I, Z iga Garc a P, Caro Maldonado A, Fernandez Ruiz S, Salvador F, Mart n Mart n N, et al. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer. J Exp Med. 2020;217: pubmed publisher
  32. Costanzo Garvey D, Keeley T, Case A, Watson G, Alsamraae M, Yu Y, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother. 2020;69:1113-1130 pubmed publisher
  33. Kluz P, Kolb R, Xie Q, Borcherding N, Liu Q, Luo Y, et al. Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling. Oncogene. 2020;39:2877-2889 pubmed publisher
  34. Dragan M, Nguyen M, Guzman S, Goertzen C, Brackstone M, Dhillo W, et al. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer. Cell Death Dis. 2020;11:106 pubmed publisher
  35. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  36. McGinn O, Ward A, Fettig L, Riley D, Ivie J, Paul K, et al. Cytokeratin 5 alters β-catenin dynamics in breast cancer cells. Oncogene. 2020;39:2478-2492 pubmed publisher
  37. Granados Soler J, Bornemann Kolatzki K, Beck J, Brenig B, Schütz E, Betz D, et al. Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival. Sci Rep. 2020;10:1003 pubmed publisher
  38. Vaidyanathan S, Salahudeen A, Sellers Z, Bravo D, Choi S, Batish A, et al. High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia. Cell Stem Cell. 2020;26:161-171.e4 pubmed publisher
  39. Davaadelger B, Choi M, Singhal H, Clare S, Khan S, Kim J. BRCA1 mutation influences progesterone response in human benign mammary organoids. Breast Cancer Res. 2019;21:124 pubmed publisher
  40. Lodes N, Seidensticker K, Perniss A, Nietzer S, Oberwinkler H, May T, et al. Investigation on Ciliary Functionality of Different Airway Epithelial Cell Lines in Three-Dimensional Cell Culture. Tissue Eng Part A. 2020;26:432-440 pubmed publisher
  41. Momcilovic M, Jones A, Bailey S, Waldmann C, Li R, Lee J, et al. In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature. 2019;575:380-384 pubmed publisher
  42. Stupnikov M, Yang Y, Mori M, LU J, Cardoso W. Jagged and Delta-like ligands control distinct events during airway progenitor cell differentiation. elife. 2019;8: pubmed publisher
  43. Jeong H, Lim K, Goldenring J, Nam K. Rab25 Deficiency Perturbs Epidermal Differentiation and Skin Barrier Function in Mice. Biomol Ther (Seoul). 2019;27:553-561 pubmed publisher
  44. Chen M, Reed R, Lane A. Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense. Cell Stem Cell. 2019;25:501-513.e5 pubmed publisher
  45. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  46. Wang H, Xiang D, Liu B, He A, Randle H, Zhang K, et al. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 2019;178:135-151.e19 pubmed publisher
  47. Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
  48. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  49. Katsura H, Kobayashi Y, Tata P, Hogan B. IL-1 and TNFα Contribute to the Inflammatory Niche to Enhance Alveolar Regeneration. Stem Cell Reports. 2019;12:657-666 pubmed publisher
  50. Krimpenfort P, Snoek M, Lambooij J, Song J, van der Weide R, Bhaskaran R, et al. A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis. Nat Commun. 2019;10:1425 pubmed publisher
  51. Forslund O, Sugiyama N, Wu C, Ravi N, Jin Y, Swoboda S, et al. A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin. BMC Cancer. 2019;19:265 pubmed publisher
  52. Jung H, Fattet L, Tsai J, Kajimoto T, Chang Q, Newton A, et al. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Nat Cell Biol. 2019;21:359-371 pubmed publisher
  53. Chen X, He Y, Xu A, Deng Z, Feng J, Lu F, et al. Increase of glandular epithelial cell clusters by an external volume expansion device promotes adipose tissue regeneration by recruiting macrophages. Biosci Rep. 2019;39: pubmed publisher
  54. Chiche A, Di Cicco A, Sesma Sanz L, Bresson L, de la Grange P, Glukhova M, et al. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling. Breast Cancer Res. 2019;21:13 pubmed publisher
  55. Sachs N, Papaspyropoulos A, Zomer van Ommen D, Heo I, Böttinger L, Klay D, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019;38: pubmed publisher
  56. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed publisher
  57. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  58. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018;49:764-779.e9 pubmed publisher
  59. Thyagarajan H, Lancaster J, Lira S, Ehrlich L. CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction. PLoS ONE. 2018;13:e0200765 pubmed publisher
  60. Pereira E, Kedrin D, Seano G, Gautier O, Meijer E, Jones D, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science. 2018;359:1403-1407 pubmed publisher
  61. Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, et al. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat Commun. 2018;9:1024 pubmed publisher
  62. Tucker A, Dyer C, Fons Romero J, Teshima T, Fuchs J, Thompson H. Mapping the distribution of stem/progenitor cells across the mouse middle ear during homeostasis and inflammation. Development. 2018;145: pubmed publisher
  63. Chen L, Hayden M, Gilmore E, Alexander Savino C, Oleksyn D, Gillespie K, et al. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis. Carcinogenesis. 2018;39:418-428 pubmed publisher
  64. Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. 2017;7:15580 pubmed publisher
  65. He H, Huang M, Sun S, Wu Y, Lin X. Epithelial heparan sulfate regulates Sonic Hedgehog signaling in lung development. PLoS Genet. 2017;13:e1006992 pubmed publisher
  66. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  67. Fettig L, McGinn O, Finlay Schultz J, LaBarbera D, Nordeen S, Sartorius C. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells. Oncogene. 2017;36:6074-6084 pubmed publisher
  68. Mamo T, Wittern A, Kleppa M, Bohnenpoll T, Weiss A, Kispert A. BMP4 uses several different effector pathways to regulate proliferation and differentiation in the epithelial and mesenchymal tissue compartments of the developing mouse ureter. Hum Mol Genet. 2017;26:3553-3563 pubmed publisher
  69. Ku A, Shaver T, Rao A, Howard J, Rodriguez C, Miao Q, et al. TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2. elife. 2017;6: pubmed publisher
  70. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  71. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  72. Egashira A, Morita M, Kumagai R, Taguchi K, Ueda M, Yamaguchi S, et al. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS ONE. 2017;12:e0173501 pubmed publisher
  73. Tao L, Xiang D, Xie Y, Bronson R, Li Z. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. Nat Commun. 2017;8:14431 pubmed publisher
  74. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  75. Butler C, Hynds R, Crowley C, Gowers K, Partington L, Hamilton N, et al. Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds. Biomaterials. 2017;124:95-105 pubmed publisher
  76. Watanabe K, Chambers J, Uchida K, Nibe K, Ushio N, Horiuchi N, et al. A cutaneous mixed tumor in a dog. J Vet Med Sci. 2017;79:670-673 pubmed publisher
  77. Anderson P, Lynch T, Engelhardt J. Multipotent Myoepithelial Progenitor Cells Are Born Early during Airway Submucosal Gland Development. Am J Respir Cell Mol Biol. 2017;56:716-726 pubmed publisher
  78. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  79. Fasano M, Della Corte C, Vicidomini G, Scotti V, Rambaldi P, Fiorelli A, et al. Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review. Oncol Lett. 2016;12:4505-4509 pubmed publisher
  80. Gomi K, Tang Y, Arbelaez V, Crystal R, Walters M. Endothelial Cell Mediated Promotion of Ciliated Cell Differentiation of Human Airway Basal Cells via Insulin and Insulin-Like Growth Factor 1 Receptor Mediated Signaling. Stem Cell Rev. 2017;13:309-317 pubmed publisher
  81. Foster M, Gwinn W, Kelly F, Brass D, Valente A, Moseley M, et al. Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017;16:538-549 pubmed publisher
  82. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  83. Lloyd Lewis B, Davis F, Harris O, Hitchcock J, Lourenco F, Pasche M, et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res. 2016;18:127 pubmed
  84. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  85. Yang Z, Peng Y, Gopalan A, Gao D, Chen Y, Joyner A. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer. Dis Model Mech. 2017;10:39-52 pubmed publisher
  86. Strietz J, Stepputtis S, Preca B, Vannier C, Kim M, Castro D, et al. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget. 2016;7:83278-83293 pubmed publisher
  87. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  88. Masili Oku S, Bacchi C, Fernandes F, Filassi J, Baracat E, Carvalho F. The Apocrine Profile of Triple-negative Breast Carcinomas in Patients Aged 45 Years or Younger: favorable but rare features. Rev Bras Ginecol Obstet. 2016;38:512-517 pubmed
  89. Sheen M, Marotti J, Allegrezza M, Rutkowski M, Conejo Garcia J, Fiering S. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 2016;5:e267 pubmed publisher
  90. Davis F, Lloyd Lewis B, Harris O, Kozar S, Winton D, Muresan L, et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat Commun. 2016;7:13053 pubmed publisher
  91. Chiche A, Moumen M, Romagnoli M, Petit V, Lasla H, Jézéquel P, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. 2017;36:2355-2365 pubmed publisher
  92. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed publisher
  93. Ren S, Luo Y, Chen H, Warburton D, Lam H, Wang L, et al. Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization. Am J Pathol. 2016;186:3261-3272 pubmed publisher
  94. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  95. Chamberland F, Maurina T, Degano Valmary S, Spicarolen T, Chaigneau L. Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization. Rare Tumors. 2016;8:5907 pubmed
  96. Hammer S, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, et al. Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines. Int J Mol Sci. 2016;17: pubmed
  97. Nielsen T, Jensen M, Burugu S, Gao D, Jørgensen C, Balslev E, et al. High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. Clin Cancer Res. 2017;23:946-953 pubmed publisher
  98. Kushitani K, Amatya V, Okada Y, Katayama Y, Mawas A, Miyata Y, et al. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology. 2017;70:375-384 pubmed publisher
  99. Cammareri P, Rose A, Vincent D, Wang J, Nagano A, Libertini S, et al. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12493 pubmed publisher
  100. Thienpont B, Steinbacher J, Zhao H, D Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63-68 pubmed publisher
  101. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  102. Schuerlein S, Schwarz T, Krziminski S, Gätzner S, Hoppensack A, Schwedhelm I, et al. A versatile modular bioreactor platform for Tissue Engineering. Biotechnol J. 2017;12: pubmed publisher
  103. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  104. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  105. Ocón B, Aranda C, Gámez Belmonte R, Suárez M, Zarzuelo A, Martinez Augustin O, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73-88 pubmed publisher
  106. Chen H, Wei Z, Sun J, Bhattacharya A, Savage D, Serda R, et al. A recellularized human colon model identifies cancer driver genes. Nat Biotechnol. 2016;34:845-51 pubmed publisher
  107. Liang Y, Zhu F, Zhang H, Chen D, Zhang X, Gao Q, et al. Conditional ablation of TGF-? signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. Sci Rep. 2016;6:29479 pubmed publisher
  108. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  109. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed publisher
  110. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  111. Su Q, Zhang B, Zhang L, Dang T, Rowley D, Ittmann M, et al. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene. 2017;36:618-627 pubmed publisher
  112. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  113. Papafotiou G, Paraskevopoulou V, Vasilaki E, Kanaki Z, Paschalidis N, Klinakis A. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat Commun. 2016;7:11914 pubmed publisher
  114. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  115. Kim J, Jeong J, Park S, Jeong J, Ryu Y, Song S. Recurrent renal cell carcinoma manifesting as a large intrathoracic fibrotic mass: A case report. Oncol Lett. 2016;11:3835-3838 pubmed
  116. Fang W, Yao M, Brummer G, Acevedo D, Alhakamy N, Berkland C, et al. Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment. Oncotarget. 2016;7:49349-49367 pubmed publisher
  117. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  118. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  119. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  120. Gomi K, Staudt M, Salit J, Kaner R, Heldrich J, Rogalski A, et al. JAG1-Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium. Stem Cell Rev. 2016;12:454-63 pubmed publisher
  121. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  122. Wang N, Dong B, Quan Y, Chen Q, Chu M, Xu J, et al. Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status. Stem Cell Reports. 2016;6:668-678 pubmed publisher
  123. Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
  124. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  125. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  126. Seo A, Lee H, Kim E, Jang M, Kim Y, Kim J, et al. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer. Br J Cancer. 2016;114:1109-16 pubmed publisher
  127. Zhu M, Bakhru P, Conley B, Nelson J, Free M, Martin A, et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat Commun. 2016;7:11350 pubmed publisher
  128. Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96-102 pubmed publisher
  129. Balasooriya G, Johnson J, Basson M, Rawlins E. An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium. Dev Cell. 2016;37:85-97 pubmed publisher
  130. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed publisher
  131. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  132. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  133. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed publisher
  134. Cammas A, Lacroix Triki M, Pierredon S, Le Bras M, Iacovoni J, Teulade Fichou M, et al. hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression. Oncotarget. 2016;7:16793-805 pubmed publisher
  135. Kim S, Kim E, Lee H, Kim M, Yoon J, Koo J, et al. Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?. Ann Surg Oncol. 2016;23:1860-6 pubmed publisher
  136. Roy J, Kim B, Hill E, Visconti P, Krapf D, Vinegoni C, et al. Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun. 2016;7:10666 pubmed publisher
  137. Johnson D, Hooker E, Luong R, Yu E, He Y, Gonzalgo M, et al. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice. PLoS ONE. 2016;11:e0148851 pubmed publisher
  138. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  139. Tadokoro T, Gao X, Hong C, Hotten D, Hogan B. BMP signaling and cellular dynamics during regeneration of airway epithelium from basal progenitors. Development. 2016;143:764-73 pubmed publisher
  140. Crowley C, Klanrit P, Butler C, Varanou A, Platé M, Hynds R, et al. Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold. Biomaterials. 2016;83:283-93 pubmed publisher
  141. Wang S, Liu J, Kim D, Datti A, Zacksenhaus E. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer. Breast Cancer Res. 2016;18:9 pubmed publisher
  142. Nalwoga H, Ahmed L, Arnes J, Wabinga H, Akslen L. Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer. PLoS ONE. 2016;11:e0146823 pubmed publisher
  143. Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans B, et al. Long-Term In Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals. Stem Cell Reports. 2016;6:150-62 pubmed publisher
  144. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  145. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  146. Bonkhoff H. Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer. Prostate. 2016;76:369-75 pubmed publisher
  147. Yoshie S, Imaizumi M, Nakamura R, Otsuki K, Ikeda M, Nomoto Y, et al. Generation of airway epithelial cells with native characteristics from mouse induced pluripotent stem cells. Cell Tissue Res. 2016;364:319-30 pubmed publisher
  148. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  149. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  150. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  151. Wang Z, Kim J, Teng Y, Ding H, Zhang J, Hai T, et al. Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells. Oncogene. 2016;35:3555-64 pubmed publisher
  152. Hurley P, Sundi D, Shinder B, Simons B, Hughes R, Miller R, et al. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016;22:448-58 pubmed publisher
  153. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed publisher
  154. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  155. Ding B, Gomi K, Rafii S, Crystal R, Walters M. Endothelial MMP14 is required for endothelial-dependent growth support of human airway basal cells. J Cell Sci. 2015;128:2983-8 pubmed publisher
  156. Goodman C, Sato T, Peck A, Girondo M, Yang N, Liu C, et al. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. Oncogene. 2016;35:1373-85 pubmed publisher
  157. Hein S, Haricharan S, Johnston A, Toneff M, Reddy J, Dong J, et al. Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress. Oncogene. 2016;35:1461-7 pubmed publisher
  158. Yuri S, Nishikawa M, Yanagawa N, Jo O, Yanagawa N. Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor. PLoS ONE. 2015;10:e0129242 pubmed publisher
  159. Berry R, Ozdemir D, Aronow B, Lindström N, Dudnakova T, Thornburn A, et al. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice. Dis Model Mech. 2015;8:903-17 pubmed publisher
  160. Eriksson P, Aine M, Veerla S, Liedberg F, Sjödahl G, Höglund M. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems. BMC Med Genomics. 2015;8:25 pubmed publisher
  161. de Deus Moura R, Carvalho F, Bacchi C. Breast cancer in very young women: Clinicopathological study of 149 patients ≤25 years old. Breast. 2015;24:461-7 pubmed publisher
  162. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  163. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  164. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  165. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  166. Liu H, Du L, Wang R, Wei C, Liu B, Zhu L, et al. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy. Oncotarget. 2015;6:11477-91 pubmed
  167. Lee S, Luong R, Johnson D, Cunha G, Rivina L, Gonzalgo M, et al. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis. Oncogene. 2016;35:702-14 pubmed publisher
  168. Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol. 2015;13:129 pubmed publisher
  169. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  170. Fausther M, Goree J, Lavoie Ã, Graham A, Sévigny J, Dranoff J. Establishment and characterization of rat portal myofibroblast cell lines. PLoS ONE. 2015;10:e0121161 pubmed publisher
  171. Savci Heijink C, Halfwerk H, Hooijer G, Horlings H, Wesseling J, van de Vijver M. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res Treat. 2015;150:547-57 pubmed publisher
  172. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed publisher
  173. Gomi K, Arbelaez V, Crystal R, Walters M. Activation of NOTCH1 or NOTCH3 signaling skews human airway basal cell differentiation toward a secretory pathway. PLoS ONE. 2015;10:e0116507 pubmed publisher
  174. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  175. Muscatello L, Sarli G, Beha G, Asproni P, Millanta F, Poli A, et al. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours. J Comp Pathol. 2015;152:153-60 pubmed publisher
  176. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  177. Weissferdt A, Rodriguez Canales J, Liu H, Fujimoto J, Wistuba I, Moran C. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. Hum Pathol. 2015;46:376-83 pubmed publisher
  178. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed publisher
  179. German S, Campbell K, Thornton E, McLachlan G, Sweetman D, Alberio R. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer. Cell Reprogram. 2015;17:19-27 pubmed publisher
  180. Tozbikian G, Brogi E, Kadota K, Catalano J, Akram M, Patil S, et al. Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival. PLoS ONE. 2014;9:e114900 pubmed publisher
  181. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  182. Sivan U, Jayakumar K, Krishnan L. Constitution of fibrin-based niche for in vitro differentiation of adipose-derived mesenchymal stem cells to keratinocytes. Biores Open Access. 2014;3:339-47 pubmed publisher
  183. Zuo W, Zhang T, Wu D, Guan S, Liew A, Yamamoto Y, et al. p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. Nature. 2015;517:616-20 pubmed publisher
  184. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  185. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  186. Chierchia L, Tussellino M, Guarino D, Carotenuto R, DeMarco N, Campanella C, et al. Cytoskeletal proteins associate with components of the ribosomal maturation and translation apparatus in Xenopus stage I oocytes. Zygote. 2015;23:669-82 pubmed publisher
  187. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  188. Sajin M, Luchian M, Hodorogea Prisăcaru A, Dumitru A, Pătraşcu O, Costache D, et al. Trichilemmal carcinoma - a rare cutaneous malignancy: report of two cases. Rom J Morphol Embryol. 2014;55:687-91 pubmed
  189. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  190. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  191. Jeon Y, Moon K, Park S, Chung D. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch. 2014;465:453-61 pubmed publisher
  192. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  193. Yun E, Baek S, Xie D, Tseng S, Dobin T, Hernandez E, et al. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1. Oncogene. 2015;34:2741-52 pubmed publisher
  194. Skogberg G, Lundberg V, Lindgren S, Gudmundsdottir J, Sandström K, Kämpe O, et al. Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype. J Immunol. 2014;193:2187-95 pubmed publisher
  195. Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed publisher
  196. Abdelzaher E, Abdallah D. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int. 2014;2014:968794 pubmed publisher
  197. Greaves E, Cousins F, Murray A, Esnal Zufiaurre A, Fassbender A, Horne A, et al. A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium. Am J Pathol. 2014;184:1930-9 pubmed publisher
  198. Rito M, Schmitt F, Pinto A, André S. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. Virchows Arch. 2014;465:185-91 pubmed publisher
  199. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, et al. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142-5 pubmed publisher
  200. Castilla M, Lopez Garcia M, Atienza M, Rosa Rosa J, Díaz Martín J, Pecero M, et al. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer. Endocr Relat Cancer. 2014;21:587-99 pubmed publisher
  201. Zhang L, Frank R, Furth E, Ziober A, LiVolsi V, Zhang P. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol. 2014;3:12 pubmed publisher
  202. Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40 pubmed publisher
  203. Uchoa D, Graudenz M, Callegari Jacques S, Hartmann C, Ferreira B, Fitarelli Kiehl M, et al. Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors. Pathol Res Pract. 2014;210:432-9 pubmed publisher
  204. Mountzios G, Aivazi D, Kostopoulos I, Kourea H, Kouvatseas G, Timotheadou E, et al. Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes. PLoS ONE. 2014;9:e91407 pubmed publisher
  205. Ryszawy D, Sarna M, Rak M, Szpak K, Kedracka Krok S, Michalik M, et al. Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer. Carcinogenesis. 2014;35:1920-30 pubmed publisher
  206. Liu Z, Yu N, Holz F, Yang F, Stanzel B. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837-50 pubmed publisher
  207. Park H, Jang M, Kim E, Kim H, Lee H, Kim Y, et al. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod Pathol. 2014;27:1212-22 pubmed publisher
  208. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  209. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  210. Tilch E, Seidens T, Cocciardi S, Reid L, Byrne D, Simpson P, et al. Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women. Breast Cancer Res Treat. 2014;143:385-92 pubmed publisher
  211. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  212. Yousem S. Immunohistochemical and molecular characterization of clear cell carcinoma of the lung. Hum Pathol. 2013;44:2467-74 pubmed publisher
  213. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  214. Andres R, Pajares I, Balmana J, Llort G, Ramon Y Cajal T, Chirivella I, et al. Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol. 2014;16:280-4 pubmed publisher
  215. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  216. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  217. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  218. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  219. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  220. Blanchard A, Ma X, Dueck K, Penner C, Cooper S, Mulhall D, et al. Claudin 1 expression in basal-like breast cancer is related to patient age. BMC Cancer. 2013;13:268 pubmed publisher
  221. Okumura N, Akutsu H, Sugawara T, Miura T, Takezawa Y, Hosoda A, et al. ?-catenin functions pleiotropically in differentiation and tumorigenesis in mouse embryo-derived stem cells. PLoS ONE. 2013;8:e63265 pubmed publisher
  222. Yakkioui Y, Temel Y, Creytens D, Jahanshahi A, Fleischeuer R, Santegoeds R, et al. A comparison of cell-cycle markers in skull base and sacral chordomas. World Neurosurg. 2014;82:e311-8 pubmed publisher
  223. Corrêa N, Kuasne H, Faria J, Seixas C, Santos I, Abreu F, et al. Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors. Oncol Rep. 2013;29:1299-307 pubmed publisher
  224. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  225. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  226. Beha G, Brunetti B, Asproni P, Muscatello L, Millanta F, Poli A, et al. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Vet Res. 2012;8:219 pubmed publisher
  227. Beha G, Sarli G, Brunetti B, Sassi F, Ferrara D, Benazzi C. Morphology of the myoepithelial cell: immunohistochemical characterization from resting to motile phase. ScientificWorldJournal. 2012;2012:252034 pubmed publisher
  228. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  229. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  230. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  231. Romero Alemán M, Monzon Mayor M, Santos E, Lang D, Yanes C. Neuronal and glial differentiation during lizard (Gallotia galloti) visual system ontogeny. J Comp Neurol. 2012;520:2163-84 pubmed publisher
  232. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  233. Ingthorsson S, Halldorsson T, Sigurdsson V, Friðriksdottir A, Bodvarsdottir S, Steinarsdottir M, et al. Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background. In Vitro Cell Dev Biol Anim. 2011;47:139-48 pubmed publisher
  234. Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed publisher
  235. Perrone F, Jocollè G, Pennati M, Deraco M, Baratti D, Brich S, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer. 2010;46:2837-48 pubmed publisher
  236. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  237. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  238. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  239. Blind C, Koepenik A, Pacyna Gengelbach M, Fernahl G, Deutschmann N, Dietel M, et al. Antigenicity testing by immunohistochemistry after tissue oxidation. J Clin Pathol. 2008;61:79-83 pubmed
  240. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  241. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  242. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  243. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed